Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
15.96
+0.85 (5.63%)
At close: May 8, 2026, 4:00 PM EDT
15.80
-0.16 (-1.00%)
After-hours: May 8, 2026, 7:39 PM EDT

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $71.14M in the quarter ending March 31, 2026, a decrease of -3.16%. This brings the company's revenue in the last twelve months to $320.35M, up 9.54% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth.

Revenue (ttm)
$320.35M
Revenue Growth
+9.54%
P/S Ratio
1.41
Revenue / Employee
$243,609
Employees
1,315
Market Cap
453.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025322.67M39.20M13.83%
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
NeoGenomics745.97M
OPKO Health581.12M
GeneDx Holdings442.68M
CareDx412.82M
Castle Biosciences339.92M
Biodesix96.10M
Prenetics Global92.39M
Revenue Rankings